Although it is commonly held that inhibition of PKC-ε would prevent cardioprotection, activation of the PKC-δ isoform showed increased damage by ischemia both in vitro and in vivo, emphasizing the need for selective PKC inhibitors [148]. Here, PRKCE is linked to ischemia.